Skip to content

Inhibrx Biosciences

US · INBX #3022 by market cap Listed 2024
68.97 -5.36 -7.21%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
D
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 3 analysts

Buy
Avg price target 266.67 +286.6%
Price target rangecurrent 68.97
Low230.00
Avg266.67
High325.00
Buy 100% Hold 0% Sell 0%
Recent ratings (16)
DateFirmAnalystRatingTarget
2026-10-29 Stifel -- Buy 325.00
2026-10-26 Stifel -- Buy 325.00
2026-09-09 H.C. Wainwright -- Buy 245.00
2026-09-08 LifeSci Capital -- Buy 230.00
2026-08-24 H.C. Wainwright -- Buy 245.00
2026-08-21 Stifel -- Buy 325.00
2026-08-14 LifeSci Capital -- Buy 230.00
2026-08-14 Stifel -- Buy 325.00
2026-06-02 Stifel -- Buy 325.00
2026-05-16 LifeSci Capital -- Buy 230.00
2026-05-15 Stifel -- Buy 325.00
2026-05-11 LifeSci Capital -- Buy 230.00
2026-04-25 LifeSci Capital -- Buy 200.00
2026-04-24 LifeSci Capital -- Buy 200.00
2026-04-22 Stifel -- Buy 300.00
2026-04-17 Stifel -- Buy 150.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Inhibrx Biosciences discussion 0 comments

Add a comment